Condition: Ventricular Tachycardia · Sponsor: Imricor Medical Systems
The VISABL-VT is a prospective, single-arm, multi-center, interventional investigation of the safety and efficacy of radiofrequency (RF) ablation of ventricular tachycardia associated with ischemic cardiomyopathy performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.
This description comes directly from the study's public registry record.
Kate Lindborg, Phd · 9528188400 · kate.lindborg@imricor.com
Always discuss trial participation with your own doctor first.
| Herzzentrum Leipzig | Leipzig, Saxony, Germany | Not Yet Recruiting |
| Amsterdam UMC | Amsterdam, Netherlands | Recruiting |
| HagaZiekenhuis | The Hague, Netherlands | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05543798